IKE Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
4,099
-165
-4% -$38.5K 0.55% 46
2026
Q1
$1.04M Buy
4,264
+560
+15% +$130K 0.59% 41
2025
Q4
$767K Buy
+3,704
New +$732K 0.67% 41

Other funds holding JNJ

IKE Capital's JNJ Position: Q2 2026 in Review

IKE Capital reduced its Johnson & Johnson (JNJ) stake by 3.9% in Q2 2026, selling an estimated $38.5K and leaving 4,099 shares worth $1.04M. The position accounts for 0.55% of the portfolio, ranked #46.

IKE Capital first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.04M in Q1 2026. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • IKE Capital held 4,099 shares of Johnson & Johnson worth $1.04M as of Q2 2026.
  • IKE Capital sold 165 Johnson & Johnson shares in Q2 2026, an estimated $38.5K.
  • Johnson & Johnson made up 0.55% of IKE Capital's portfolio in Q2 2026, its #46 holding.
  • IKE Capital first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • IKE Capital's Johnson & Johnson position peaked at $1.04M in Q1 2026.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on IKE Capital's 13F filing for Q2 2026, filed 16 Sep 2026.